Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve The Unaudited Financial ....
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has informed stock exchanges that its Board of Directors will meet on Monday, February 9, 2026, to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company has also confirmed that the trading window for dealing in its equity shares remains closed from January 1, 2026, until 48 hours after the results are declared, in line with its Insider Trading Code. This is a routine regulatory disclosure under SEBI Listing Regulations and does not contain any results or financial numbers at this stage.
No direct impact on stock price from this notice alone. Investors should watch the Q3 FY26 results on February 9, 2026 for actual revenue, profit and margin numbers that could move the stock. The closed trading window means insiders cannot trade until results are out.